432 related articles for article (PubMed ID: 28668085)
41. Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.
van Schaik IN; van Geloven N; Bril V; Hartung HP; Lewis RA; Sobue G; Lawo JP; Mielke O; Cornblath DR; Merkies IS;
Trials; 2016 Jul; 17(1):345. PubMed ID: 27455854
[TBL] [Abstract][Full Text] [Related]
42. Genetic biomarkers for intravenous immunoglobulin response in chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van Doorn PA; Bengrine T; van Rijs W; Baas F; Nagelkerke SQ; Kuijpers TW; Fokkink WR; Bunschoten C; Broers MC; Willemsen SP; Jacobs BC; Huizinga R
Eur J Neurol; 2021 May; 28(5):1677-1683. PubMed ID: 33460483
[TBL] [Abstract][Full Text] [Related]
43. Severe Chronic Inflammatory Demyelinating Polyneuropathy Ameliorated following High-dose (3 g/kg) Intravenous Immunoglobulin Therapy.
Seino Y; Nakamura T; Hirohata M; Kawarabayashi T; Okushima T; Shoji M
Intern Med; 2019 Mar; 58(6):855-859. PubMed ID: 30449785
[TBL] [Abstract][Full Text] [Related]
44. Combined intravenous immunoglobulin and methylprednisolone as induction treatment in chronic inflammatory demyelinating polyneuropathy (OPTIC protocol): a prospective pilot study.
Adrichem ME; Bus SR; Wieske L; Mohammed H; Verhamme C; Hadden R; van Schaik IN; Eftimov F
Eur J Neurol; 2020 Mar; 27(3):506-513. PubMed ID: 31571349
[TBL] [Abstract][Full Text] [Related]
45. Timing and course of clinical response to intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy.
Latov N; Deng C; Dalakas MC; Bril V; Donofrio P; Hanna K; Hartung HP; Hughes RA; Merkies IS; van Doorn PA;
Arch Neurol; 2010 Jul; 67(7):802-7. PubMed ID: 20457948
[TBL] [Abstract][Full Text] [Related]
46. Management of chronic inflammatory demyelinating polyradiculoneuropathy.
Hughes RA
Drugs; 2003; 63(3):275-87. PubMed ID: 12534332
[TBL] [Abstract][Full Text] [Related]
47. Chronic inflammatory demyelinating polyneuropathy as an autoimmune disease.
Rodríguez Y; Vatti N; Ramírez-Santana C; Chang C; Mancera-Páez O; Gershwin ME; Anaya JM
J Autoimmun; 2019 Aug; 102():8-37. PubMed ID: 31072742
[TBL] [Abstract][Full Text] [Related]
48. Clinical trials in CIDP and chronic autoimmune demyelinating polyneuropathies.
Dalakas MC
J Peripher Nerv Syst; 2012 May; 17 Suppl 2():34-9. PubMed ID: 22548621
[TBL] [Abstract][Full Text] [Related]
49. Intravenous immunoglobulin in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): mechanisms of action and clinical and genetic considerations.
Dalakas MC; Latov N; Kuitwaard K
Expert Rev Neurother; 2022; 22(11-12):953-962. PubMed ID: 36645654
[TBL] [Abstract][Full Text] [Related]
50. A new treatment regimen with high-dose and fractioned immunoglobulin in a special subgroup of severe and dependent CIDP patients.
Debs R; Reach P; Cret C; Demeret S; Saheb S; Maisonobe T; Viala K
Int J Neurosci; 2017 Oct; 127(10):864-872. PubMed ID: 27918219
[TBL] [Abstract][Full Text] [Related]
51. Investigations and treatment of chronic inflammatory demyelinating polyradiculoneuropathy and other inflammatory demyelinating polyneuropathies.
Tracy JA; Dyck PJ
Curr Opin Neurol; 2010 Jun; 23(3):242-8. PubMed ID: 20389243
[TBL] [Abstract][Full Text] [Related]
52. [Topics of chronic inflammatory demyelinating polyradiculoneuropathy--diagnosis and treatment situation in Japan].
Iijima M
Rinsho Byori; 2013 May; 61(5):407-13. PubMed ID: 23947179
[TBL] [Abstract][Full Text] [Related]
53. Subcutaneous immunoglobulin as first-line therapy in treatment-naive patients with chronic inflammatory demyelinating polyneuropathy: randomized controlled trial study.
Markvardsen LH; Sindrup SH; Christiansen I; Olsen NK; Jakobsen J; Andersen H;
Eur J Neurol; 2017 Feb; 24(2):412-418. PubMed ID: 28000311
[TBL] [Abstract][Full Text] [Related]
54. Current treatments of chronic immune-mediated demyelinating polyneuropathies.
Brannagan TH
Muscle Nerve; 2009 May; 39(5):563-78. PubMed ID: 19301378
[TBL] [Abstract][Full Text] [Related]
55. [Treatment's initiation in chronic inflammatory demyelinating polyradiculopathy (CIDP)].
Uzenot D; Azulay JP; Pouget J
Rev Neurol (Paris); 2007 Sep; 163 Spec No 1():3S68-76. PubMed ID: 18087233
[TBL] [Abstract][Full Text] [Related]
56. Pediatric-Onset Chronic Inflammatory Demyelinating Polyneuropathy: A Multicenter Study.
Sarıkaya Uzan G; Vural A; Yüksel D; Aksoy E; Öztoprak Ü; Canpolat M; Öztürk S; Yıldırım Ç; Güleç A; Per H; Gümüş H; Okuyaz Ç; Çobanoğulları Direk M; Kömür M; Ünalp A; Yılmaz Ü; Bektaş Ö; Teber S; Aliyeva N; Olgaç Dündar N; Gençpınar P; Gürkaş E; Keskin Yılmaz S; Kanmaz S; Tekgül H; Aksoy A; Öz Tuncer G; Acar Arslan E; Tosun A; Ayanoğlu M; Kızılırmak AB; Yousefi M; Bodur M; Ünay B; Hız Kurul S; Yiş U
Pediatr Neurol; 2023 Aug; 145():3-10. PubMed ID: 37245275
[TBL] [Abstract][Full Text] [Related]
57. Randomised controlled trial comparing two different intravenous immunoglobulins in chronic inflammatory demyelinating polyradiculoneuropathy.
Kuitwaard K; van den Berg LH; Vermeulen M; Brusse E; Cats EA; van der Kooi AJ; Notermans NC; van der Pol WL; van Schaik IN; van Nes SI; Hop WC; van Doorn PA
J Neurol Neurosurg Psychiatry; 2010 Dec; 81(12):1374-9. PubMed ID: 20587484
[TBL] [Abstract][Full Text] [Related]
58. Restabilization treatment after intravenous immunoglobulin withdrawal in chronic inflammatory demyelinating polyneuropathy: Results from the pre-randomization phase of the Polyneuropathy And Treatment with Hizentra study.
Mielke O; Bril V; Cornblath DR; Lawo JP; van Geloven N; Hartung HP; Lewis RA; Merkies ISJ; Sobue G; Durn B; Shebl A; van Schaik IN;
J Peripher Nerv Syst; 2019 Mar; 24(1):72-79. PubMed ID: 30672067
[TBL] [Abstract][Full Text] [Related]
59. Chronic inflammatory lumbosacral polyradiculopathy: a regional variant of CIDP.
Caporale CM; Staedler C; Gobbi C; Bassetti CL; Uncini A
Muscle Nerve; 2011 Nov; 44(5):833-7. PubMed ID: 22006701
[TBL] [Abstract][Full Text] [Related]
60. Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.
Chan YC; Allen DC; Fialho D; Mills KR; Hughes RA
J Neurol Neurosurg Psychiatry; 2006 Jan; 77(1):114-6. PubMed ID: 16361609
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]